Doxapram for apnoea of prematurity and neurodevelopmental outcomes at age 5-6 years.
Tréluyer L, Zana-Taieb E, Jarreau PH, Benhammou V, Kuhn P, Letouzey M, Marchand-Martin L, Onland W, Pierrat V, Saade L, Ancel PY, Torchin H.
Tréluyer L, et al.
Arch Dis Child Fetal Neonatal Ed. 2024 Jan 16:fetalneonatal-2023-326170. doi: 10.1136/archdischild-2023-326170. Online ahead of print.
Arch Dis Child Fetal Neonatal Ed. 2024.
PMID: 38228381